Trial Profile
Clinical Trials Insight: 700060668
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2010
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis; Ulcerative proctitis
- Focus Therapeutic Use
- 28 Oct 2010 New trial record
- 20 Oct 2010 Results reported at the 75th Annual Scientific Meeting of the American College of Gastroenterology